HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low-dose thalidomide in myelofibrosis.

AuthorsRobert Weinkove, John T Reilly, Mary Frances McMullin, Natasha J Curtin, Deepti Radia, Claire N Harrison
JournalHaematologica (Haematologica) Vol. 93 Issue 7 Pg. 1100-1 (Jul 2008) ISSN: 1592-8721 [Electronic] Italy
PMID18508796 (Publication Type: Clinical Trial, Letter)
Chemical References
  • Immunosuppressive Agents
  • Thalidomide
  • Prednisolone
Topics
  • Aged
  • Aged, 80 and over
  • Blood Transfusion
  • Female
  • Humans
  • Immunosuppressive Agents (administration & dosage)
  • Male
  • Middle Aged
  • Prednisolone (therapeutic use)
  • Primary Myelofibrosis (diagnosis, drug therapy)
  • Spleen (drug effects)
  • Stem Cell Transplantation (methods)
  • Thalidomide (administration & dosage)
  • Transplantation, Homologous
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: